Today: 27 April 2026
Browse Category

Stock Market 18 December 2025

Goldman Sachs Stock (GS) Rises on Dec. 18, 2025: Latest News, Analyst Price Targets, and the 2026 Outlook

Goldman Sachs Stock (GS) Rises on Dec. 18, 2025: Latest News, Analyst Price Targets, and the 2026 Outlook

Goldman Sachs shares traded in the high-$870s on December 18, up modestly as softer U.S. inflation data and Dow gains supported financial stocks. The bank hired Brian Cayne, co-founder of Qatalyst Partners, as global co-head of software investment banking. Goldman led global tech M&A by deal value in 2025, advising on $337.8 billion in transactions.
AppLovin (APP) Stock Surges on Dec. 18, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching

AppLovin (APP) Stock Surges on Dec. 18, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching

AppLovin shares jumped 5%–6% to near $694 by midday Thursday after the Czech National Bank disclosed a new $49.4 million stake. The stock’s market cap hovered above $200 billion, up 103% year-to-date. Insider selling totaled about $195 million over the past three months, including sales by CEO Arash Adam Foroughi and director Eduardo Vivas. Institutional ownership stands at roughly 41.85%.
18 December 2025
Cisco Stock News Today (Dec. 18, 2025): CSCO Rises as Wall Street Lifts Targets—But a Critical Zero‑Day Cyber Alert Adds Risk

Cisco Stock News Today (Dec. 18, 2025): CSCO Rises as Wall Street Lifts Targets—But a Critical Zero‑Day Cyber Alert Adds Risk

Cisco stock rose 1.5% to $77.15 on December 18 after Morgan Stanley reaffirmed its “Overweight” rating and analysts raised targets. Meanwhile, Cisco warned that China-linked attackers are actively exploiting a critical zero-day flaw in its Secure Email products, with no patch available. Singapore’s Cyber Security Agency rated the vulnerability CVE-2025-20393 at 10/10 severity. Trading volume reached 6.14 million shares.
Warner Bros. Discovery (WBD) Series A Stock: Standard General CNN Talks, Netflix Deal vs Paramount Bid, and Analyst Forecasts on Dec. 18, 2025

Warner Bros. Discovery (WBD) Series A Stock: Standard General CNN Talks, Netflix Deal vs Paramount Bid, and Analyst Forecasts on Dec. 18, 2025

Warner Bros. Discovery shares fell about 1% to $27.93 on Dec. 18 after reports that hedge fund Standard General is in talks to invest in or acquire parts of WBD’s networks business, including CNN. The board urged shareholders to reject Paramount Skydance’s tender offer, backing a rival deal with Netflix. Morgan Stanley raised its price target for WBD to $29 amid shifting deal dynamics.
Linde plc Stock (LIN) in Focus on Dec. 18, 2025: New CFO Space Board Role, EPS Guidance, and Analyst Targets Near $500

Linde plc Stock (LIN) in Focus on Dec. 18, 2025: New CFO Space Board Role, EPS Guidance, and Analyst Targets Near $500

Linde shares traded near $422 midday Dec. 18 after CFO Matt White joined Stoke Space’s board, highlighting the company’s push into commercial space. The Czech National Bank increased its stake in Linde during Q3, according to filings. Analysts continue to cite strong earnings potential despite a premium valuation and mixed industrial trends.
Costco Stock (COST) Today: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 18, 2025

Costco Stock (COST) Today: Latest News, Analyst Forecasts, and Key Catalysts to Watch on Dec. 18, 2025

Costco shares traded at $859.54, down 0.36% as of 11:50 a.m. ET on Dec. 18, with a market cap near $381 billion. Investors are weighing strong fiscal Q1 2026 results—net sales of $65.98 billion, net income of $2.001 billion—against concerns over valuation and a slight dip in membership renewal rates. A recent “Sell” call and lack of formal guidance have added to the debate.
18 December 2025
Coinbase Stock (COIN) Today: “Everything Exchange” Expansion, Analyst Price Targets, and Key Catalysts to Watch (Dec. 18, 2025)

Coinbase Stock (COIN) Today: “Everything Exchange” Expansion, Analyst Price Targets, and Key Catalysts to Watch (Dec. 18, 2025)

Coinbase shares rose 2.3% to $249.80 on Dec. 18, 2025, after launching U.S. stock and ETF trading for retail users. The company also announced new prediction markets and previewed plans for tokenized equities. Bitcoin traded near $87,678 as crypto prices stabilized. Regulatory questions remain over Coinbase’s expansion into event contracts and tokenized assets.
18 December 2025
Uber Stock Today (NYSE: UBER): Robotaxi Debate Heats Up as Analysts Reprice the Risk — What Investors Are Watching on Dec. 18, 2025

Uber Stock Today (NYSE: UBER): Robotaxi Debate Heats Up as Analysts Reprice the Risk — What Investors Are Watching on Dec. 18, 2025

Uber shares traded near $80 on December 18, 2025, giving the company a market cap of about $164 billion. Bernstein reiterated its Outperform rating and $115 price target, saying robotaxi concerns are overstated. Reuters reported Uber is linked to robotaxi testing in Munich with Momenta in 2026. The stock has swung between the high-$50s and over $100 in the past year.
GE Vernova Stock (NYSE: GEV) Rebounds on Dec. 18, 2025 as Jefferies Upgrades; Analysts Lift Targets After AI-Driven Selloff

GE Vernova Stock (NYSE: GEV) Rebounds on Dec. 18, 2025 as Jefferies Upgrades; Analysts Lift Targets After AI-Driven Selloff

GE Vernova shares rebounded 4% Thursday to around $641 after plunging 10%–11% Wednesday, the S&P 500’s worst drop that day. The selloff followed concerns that more efficient AI chips could slow electricity demand growth, triggered in part by funding news for AI chip startup Mythic. Jefferies upgraded the stock to “Buy” Thursday, citing strong multi-year fundamentals and demand for power equipment.
18 December 2025
Micron Technology Stock (MU) Surges on Blowout Guidance: AI HBM Demand, Supply Crunch, and New Analyst Targets (Dec. 18, 2025)

Micron Technology Stock (MU) Surges on Blowout Guidance: AI HBM Demand, Supply Crunch, and New Analyst Targets (Dec. 18, 2025)

Micron shares surged nearly 12% to $252.34 on Dec. 18 after the company posted record fiscal Q1 revenue of $13.6 billion and issued a bullish Q2 outlook. The company reported DRAM revenue of $10.8 billion, non-GAAP EPS of $4.78, and guided for Q2 revenue of $18.7 billion with gross margin at 68%. Investors responded to strong AI-driven demand and tight memory supply.
18 December 2025
Eaton Stock (NYSE: ETN) News & Forecast for Dec. 18, 2025: Wells Fargo Cuts Target, Analysts Debate Valuation, and the AI Data Center Growth Thesis

Eaton Stock (NYSE: ETN) News & Forecast for Dec. 18, 2025: Wells Fargo Cuts Target, Analysts Debate Valuation, and the AI Data Center Growth Thesis

Eaton shares rose 0.8% to around $318 Thursday after plunging 4.28% on heavy volume Wednesday, underperforming industrial peers. Wells Fargo cut its price target to $340 from $395, citing valuation concerns, but kept an Equal Weight rating. The stock remains about 20% below its July high. Analyst targets still average above $399, though opinions are diverging.
18 December 2025
Semiconductor Stocks Rally at Midday (Dec. 18, 2025): Micron Ignites the AI-Memory Trade as CPI Cools and Chip ETFs Jump

Semiconductor Stocks Rally at Midday (Dec. 18, 2025): Micron Ignites the AI-Memory Trade as CPI Cools and Chip ETFs Jump

Micron shares jumped nearly 12% midday Thursday after the company forecast second-quarter profit almost double Wall Street estimates, citing strong AI-driven memory demand. The rally lifted the Philadelphia Semiconductor Index about 2.8%, with Nvidia, AMD, and TSMC also higher. Investors responded to both Micron’s outlook and softer U.S. inflation data. Some analysts flagged data-quality concerns linked to the recent government shutdown.
Trump Media (DJT) Stock Surges After $6 Billion Fusion Merger With TAE: News, Forecasts, and What Comes Next (Dec. 18, 2025)

Trump Media (DJT) Stock Surges After $6 Billion Fusion Merger With TAE: News, Forecasts, and What Comes Next (Dec. 18, 2025)

Trump Media & Technology Group shares jumped 34.77% to $14.11 on Dec. 18 after announcing a $6 billion all-stock merger with TAE Technologies, a private nuclear fusion firm backed by Google. The combined company will be co-led by Devin Nunes and Michl Binderbauer, with each side owning about 50%. Trump Media committed up to $300 million in cash. The deal aims to close by mid-2026.
US Space and Defense Stocks Today: Midday Market Movers, Taiwan Arms Package, Rocket Lab’s Space Force Launch, and the White House NDAA Timeline (Dec. 18, 2025)

US Space and Defense Stocks Today: Midday Market Movers, Taiwan Arms Package, Rocket Lab’s Space Force Launch, and the White House NDAA Timeline (Dec. 18, 2025)

U.S. aerospace and defense ETFs outperformed the broader market at midday Thursday, with ITA up 2.14%, XAR up 2.27%, and PPA up 1.47%. The S&P 500 ETF rose 1.35%. Investors weighed softer inflation data against White House discussions of possible limits on buybacks, dividends, and executive pay for contractors with delayed or over-budget projects. Major defense primes traded mixed.
Big Tech Stocks Today: Magnificent Seven Rally Near Noon ET as Soft Inflation and AI Demand Reset the Narrative

Big Tech Stocks Today: Magnificent Seven Rally Near Noon ET as Soft Inflation and AI Demand Reset the Narrative

Big Tech stocks rebounded by midday Thursday, December 18, 2025, with the Magnificent Seven all higher after a benign November inflation report and strong Micron earnings. Nasdaq rose about 2% by late morning, S&P 500 up 1.4%, and Dow up 1%. The 10-year Treasury yield dipped to 4.12%. CPI data was limited due to a 43-day government shutdown, leaving investors with less clarity on near-term trends.

Stock Market Today

  • PTC Therapeutics (PTCT) Stock Valuation and Pipeline Developments Reviewed
    April 27, 2026, 3:00 AM EDT. Shares of PTC Therapeutics (NASDAQ: PTCT) hovered at $68.23, reflecting mixed short-term performance but a 38% gain over the past year. The biotech's valuation appears 22% undervalued compared with a fair value estimate near $87.87, driven by late-stage pipeline advancements. Notably, two new drug applications (NDAs) are under FDA review - vatiquinone for Friedreich's ataxia and Translarna - alongside an upcoming Phase 3 trial for Huntington's disease treatment PTC518 in partnership with Novartis. These developments may broaden product offerings and diversify revenue. However, risks include reliance on a narrow product base and ongoing losses. Investors should weigh potential growth against uncertainties around market access and adoption. The current setup calls for cautious evaluation amid shifting momentum in healthcare stocks.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 27.04.2026

27 April 2026
LIVEMarkets rolling coverageStarted: April 27, 2026, 12:00 AM EDTUpdated: April 27, 2026, 3:03 AM EDT PTC Therapeutics (PTCT) Stock Valuation and Pipeline Developments Reviewed April 27, 2026, 3:00 AM EDT. Shares of PTC Therapeutics (NASDAQ: PTCT) hovered at $68.23, reflecting mixed short-term performance but a 38% gain over the past year. The biotech's valuation appears 22% undervalued compared with a fair value estimate near $87.87, driven by late-stage pipeline advancements. Notably, two new drug applications (NDAs) are under FDA review – vatiquinone for Friedreich's ataxia and Translarna – alongside an upcoming Phase 3 trial for Huntington's disease treatment PTC518 in
Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

26 April 2026
Kratos Defense shares dropped 6.5% to $61.26, cutting its market value to $10.6 billion as investors questioned the pace of profit from new contracts. The company recently completed the first flight of its Mk1 Firejet drone and won a Space Force contract worth up to $446.8 million. AeroVironment, L3Harris, and Northrop Grumman also declined. Kratos raised $1.17 billion in a February share offering.
Robinhood’s Earnings Week Now Has a Prediction-Market Problem

Robinhood’s Earnings Week Now Has a Prediction-Market Problem

26 April 2026
Wisconsin sued Robinhood and several rivals over sports event contracts, alleging illegal sports betting through prediction markets. The lawsuit comes days before Robinhood reports first-quarter earnings on Tuesday. Robinhood shares closed at $84.71 Friday, down from $91.28 on Monday. The company said its event contracts are federally regulated and it will defend itself.
Go toTop